Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.35 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.34 |
| ▸ | CD81 | P60033 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | FNTB | P49356 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9486198 | 0.87 | AKR1C3 (0.39) | AKR1C3GRIK2CD81CYP2C9PTGS1 | |
| SCHEMBL9486204 | 0.87 | AKR1C3 (0.39) | AKR1C3GRIK2CD81CYP2C9PTGS1 | |
| SCHEMBL1774518 | 0.82 | AKR1C3 (0.42) | AKR1C3GRIK2CD81CYP2C9PTGS1 | |
| SCHEMBL1774515 | 0.82 | AKR1C3 (0.42) | AKR1C3GRIK2CD81CYP2C9PTGS1 | |
| SCHEMBL35841 | 0.81 | AKR1C3 (0.35) | AKR1C3GRIK2CD81CYP2C9PTGS1 | |
| SCHEMBL852778 | 0.81 | AKR1C3 (0.35) | AKR1C3GRIK2CD81CYP2C9PTGS1 | |
| SCHEMBL3126999 | 0.81 | AKR1C3 (0.35) | AKR1C3GRIK2CD81CYP2C9PTGS1 | |
| SCHEMBL700124 | 0.81 | AKR1C3 (0.35) | AKR1C3GRIK2CD81CYP2C9PTGS1 | |
| SCHEMBL1135821 | 0.81 | TSHR (0.42) | AKR1C3GRIK2PTGS1 | |
| SCHEMBL6442141 | 0.79 | AKR1C3 (0.34) | AKR1C3GRIK2CD81CYP2C9PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6689588-B1 | USE IN COLUMN CONTAINING THE IMMOBILIZED ALLIINASE AND COLLECTING PURE ALLICIN IN EFFLUENT; PURE ALLICIN HAS AS FOOD ADDITIVE OR PHARMACEUTICAL FOR INFECTIONS, THROMBOSIS OR HYPERLIPIDEMIA | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2004-02-10 | — | — | US | disclosed |
| EP-0904361-A1 | IMMOBILIZED ALLIINASE AND CONTINUOUS PRODUCTION OF ALLICIN | YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD. (IL) | 1999-03-31 | — | — | EP | disclosed |
| WO-1997039115-A1 | IMMOBILIZED ALLIINASE AND CONTINUOUS PRODUCTION OF ALLICIN | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1997-10-23 | — | — | WO | disclosed |